Market Cap: $210.61M
Market Cap: $210.61M

Arcturus Therapeutics Holdings (NASDAQ: ARCT) is a San Diego-based clinical-stage mRNA company built around two proprietary technologies: the LUNAR lipid-mediated delivery platform and STARR self-ampl…
Arcturus Therapeutics: Reinventing mRNA Innovation Arcturus Therapeutics Holdings, a key player in the rapidly evolving biopharmaceutical landscape, exhibits remarkable momentum as it reports a 25% ye…
Anticipation Builds for Arcturus Therapeutics’ Quarterly Earnings Report With March 3, 2026, on the horizon, Arcturus Therapeutics Holdings finds itself in a crucial phase as it prepares to unveil its…
Anticipating Earnings: A Pivotal Moment for Arcturus Therapeutics Arcturus Therapeutics Holdings, a prominent player in the biopharmaceutical sector, prepares to unveil its quarterly earnings report o…
Open
$7.18
Prev. Close
$6.08
High
$7.665
Low
$7.13